Binghai Zhou
- Molecular Biology
- Cancer Research top 10%
- Oncology
- Immunology
- Hepatology top 10%
- Topics
- Cancer Immunotherapy and Biomarkers (7 papers)Hepatocellular Carcinoma Treatment and Prognosis (6 papers)Cancer, Lipids, and Metabolism (3 papers)
- Cited by
- HepatologyCancer ResearchImmunology
- Journals
- SHILAP Revista de lepidopterologíaBiochemical and Biophysical Research CommunicationsFrontiers in Immunology
In The Last Decade
Binghai Zhou
24 papers receiving 495 citations
Peers
Comparison fields: 5 of 64
- Molecular Biology 207
- Cancer Research 175
- Oncology 129
- Immunology 126
- Hepatology 97
Countries citing papers authored by Binghai Zhou
This map shows the geographic impact of Binghai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binghai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binghai Zhou more than expected).
Fields of papers citing papers by Binghai Zhou
This network shows the impact of papers produced by Binghai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binghai Zhou. The network helps show where Binghai Zhou may publish in the future.
Co-authorship network of co-authors of Binghai Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Binghai Zhou. A scholar is included among the top collaborators of Binghai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binghai Zhou. Binghai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Exosomes with IR780 and Lenvatinib loaded on GPC3 single-chain scFv antibodies for targeted hyperthermia and chemotherapy in hepatocellular carcinoma therapy. | 5 |
| 3 | 9 | |
| 4 | 13 | |
| 5 | 21 | |
| 6 | 7 | |
| 7 | 36 | |
| 8 | 2 | |
| 9 | 28 | |
| 10 | 7 | |
| 11 | GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma. | 16 |
| 12 | 48 | |
| 13 | 14 | |
| 14 | 15 | |
| 15 | Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma. | 71 |
| 16 | 44 | |
| 17 | 23 | |
| 18 | 83 | |
| 19 | 5 | |
| 20 | [Study on some metal elements levels and the T lymphocyte subset of the peripheral lymphocytes in patients with nasopharyngeal carcinomas]. | 1 |
About Binghai Zhou
Binghai Zhou is a scholar working on Hepatology, Cancer Research and Oncology, having authored 24 papers that have together received 499 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Hepatology (97 citations), Cancer Research (175 citations) and Immunology (126 citations). Binghai Zhou has collaborated with scholars based in China, Ethiopia and Taiwan. Frequent co-authors include Qing‐Hai Ye, Lei Guo, Jiuliang Yan, Jia Fan, Mincheng Yu, Yongfeng Xu, Yong‐Sheng Xiao, Bin Jin, Zheng Chen and Gang Du. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.